An observational study on early empiric versus culture-directed antifungal therapy in critically ill with intra-abdominal sepsis

Critical Care Research and Practice

Volumn 2014, Issue , 2014, Pages

  Lee, Winnie ^a   Liew, Yixin ^a   Chlebicki, Maciej Piotr ^a   Ong, Sharon ^a   Lee, Pang ^a   Kwa, Andrea ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901774653     PISSN: 20901305     EISSN: 20901313     Source Type: Journal    
DOI: 10.1155/2014/479413     Document Type: Article

References (34)

1. Ostrosky-Zeichner L., New approaches to the risk of Candida in the intensive care unit. Current Opinion in Infectious Diseases 2003 16 6 533 537 2-s2.0-2442490144
2. Garey K. W., Neuhauser M. M., Bearden D. T., Cannon J. P., Lewis R. E., Gentry L. O., Kontoyiannis D. P., Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses 2006 49 3 226 231 2-s2.0-33646228401 10.1111/j.1439-0507.2006.01222.x
3. Marriot D. J., Playford E. G., Chan S., Determinants of mortality in non-neutropenic ICU patients with candidemia. Critical Care 2009 13 4 R115
4. Méan M., Marchetti O., Calandra T., Bench-to-bedside review: candida infections in the intensive care unit. Critical Care 2008 12 1, article 204 2-s2.0-45549092114 10.1186/cc6212
5. Muñoz P., Burillo A., Bouza E., Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. International Journal of Antimicrobial Agents 2000 15 2 83 90 2-s2.0-0342657756 10.1016/S0924-8579(00)00147-3 (Pubitemid 30347248)
6. Playford E. G., Lipman J., Sorrell T. C., Management of invasive candidiasis in the intensive care unit. Drugs 2010 70 7 823 839 2-s2.0-77951724037 10.2165/10898550-000000000-00000
7. Pfaller M. A., Diekema D. J., Epidemiology of invasive candidiasis: a persistent public health problem. Clinical Microbiology Reviews 2007 20 1 133 163 2-s2.0-33846466508 10.1128/CMR.00029-06 (Pubitemid 46167771)
8. Rangel-Frausto M. S., Wiblin T., Blumberg H. M., Saiman L., Patterson J., Rinaldi M., Pfaller M., Edwards J. E. Jr., Jarvis W., Dawson J., Wenzel R. P., National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clinical Infectious Diseases 1999 29 2 253 258 2-s2.0-0032788359 (Pubitemid 29380179)
9. Weigand M. A., Lichtenstern C., Bottiger B. W., Antifungal therapy in surgical ICU patients. Yearbook of Intensive Care & Emergency Medicine 2006 613 623
10. Marchetti O., Eggimann P., Calandra T., Invasive candidiasis in critically ill patients: does progressing knowledge improve clinical management and outcome? Current Opinion in Critical Care 2010 16 5 442 444 2-s2.0-78449270669 10.1097/MCC.0b013e32833e2629
11. Playford E. G., Lipman J., Sorrell T. C., Prophylaxis, empirical and preemptive treatment of invasive candidiasis. Current Opinion in Critical Care 2010 16 5 470 474 2-s2.0-78449284889 10.1097/MCC.0b013e32833e10e8
12. Garey K. W., Rege M., Pai M. P., Mingo D. E., Suda K. J., Turpin R. S., Bearden D. T., Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clinical Infectious Diseases 2006 43 1 25 31 2-s2.0-33745313876 10.1086/504810 (Pubitemid 43939072)
13. Morrell M., Fraser V. J., Kollef M. H., Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrobial Agents and Chemotherapy 2005 49 9 3640 3645 2-s2.0-24144483474 10.1128/AAC.49.9.3640- 3645.2005 (Pubitemid 41233011)
14. Hsueh P.-R., Graybill J. R., Playford E. G., Watcharananan S. P., Oh M.-D., Ja'alam K., Huang S., Nangia V., Kurup A., Padiglione A. A., Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region. International Journal of Antimicrobial Agents 2009 34 3 205 209 2-s2.0-67650759720 10.1016/j.ijantimicag.2009.03.014
15. Shan Y.-S., Sy E. D., Wang S.-T., Lee J.-C., Lin P.-W., Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. World Journal of Surgery 2006 30 1 119 126 2-s2.0-30544450733 10.1007/s00268-005-7807-z (Pubitemid 43081623)
16. Eggimann P., Francioli P., Bille J., Schneider R., Wu M.-M., Chapuis G., Chiolero R., Pannatier A., Schilling J., Geroulanos S., Glauser M. P., Calandra T., Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Critical Care Medicine 1999 27 6 1066 1072 2-s2.0-0033047638 10.1097/00003246-199906000-00019 (Pubitemid 29314312)
17. Pelz R. K., Hendrix C. W., Swoboda S. M., Diener-West M., Merz W. G., Hammond J., Lipsett P. A., Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically III surgical patients. Annals of Surgery 2001 233 4 542 548 2-s2.0-0035080325 10.1097/00000658-200104000-00010 (Pubitemid 32234953)
18. Garbino J., Lew D. P., Jacques-A. Romand J.-A. R., Hugonnet S., Auckenthaler R., Pittet D., Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Medicine 2002 28 12 1708 1717 2-s2.0-0036453937 10.1007/s00134-002-1540-y (Pubitemid 35435471)
19. Playford E. G., Webster A. C., Sorrell T. C., Craig J. C., Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database of Systematic Reviews 2006 1 CD004920 2-s2.0-33645520637
20. Shorr A. F., Chung K., Jackson W. L., Waterman P. E., Kollef M. H., Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Critical Care Medicine 2005 33 9 1928 1935 2-s2.0-24944510786 10.1097/01.CCM.0000178352.14703.49 (Pubitemid 41306511)
21. Pappas P. G., Kauffman C. A., Andes D., Benjamin D. K. Jr., Calandra T. F., Edwards J. E. Jr., Filler S. G., Fisher J. F., Kullberg B.-J., Ostrosky-Zeichner L., Reboli A. C., Rex J. H., Walsh T. J., Sobel J. D., Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009 48 5 503 535 2-s2.0-60549098868 10.1086/596757
22. Piarroux R., Grenouillet F., Balvay P., Tran V., Blasco G., Millon L., Boillot A., Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Critical Care Medicine 2004 32 12 2443 2449 2-s2.0-10644283859 10.1097/01.CCM.0000147726.62304.7F (Pubitemid 39648226)
23. Eggimann P., Marchetti O., Is (1→3)- β -D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Critical Care 2011 15 6, article 1017 2-s2.0-83455210190 10.1186/cc10544
24. Blot S., Dimopoulos G., Rello J., Vogelaers D., Is Candida really a threat in the ICU? Current Opinion in Critical Care 2008 14 5 600 604 2-s2.0-55349131727 10.1097/MCC.0b013e32830f1dff
25. Vardakas K. Z., Michalopoulos A., Kiriakidou K. G., Siampli E. P., Samonis G., Falagas M. E., Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients. Clinical Microbiology and Infection 2009 15 3 289 292 2-s2.0-63249101418 10.1111/j.1469-0691.2008. 02653.x
26. Lam S. W., Eschenauer G. A., Carver P. L., Evolving role of early antifungals in the adult intensive care unit. Critical Care Medicine 2009 37 5 1580 1593 2-s2.0-67650486325 10.1097/CCM.0b013e31819dec9b
27. Cornely O. A., Bassetti M., Calandra T., ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical Microbiology and Infection 2012 18 supplement 7 19 37
28. Nolla-Salas J., Sitges-Serra A., Leon-Fil C., Candidemia in non-neutropenic critically-ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Medicine 1997 23 23 30 (Pubitemid 27067892)
29. Zilberberg M. D., Kollef M. H., Arnold H., Labelle A., Micek S. T., Kothari S., Shorr A. F., Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infectious Diseases 2010 10, article 150 2-s2.0-77954038544 10.1186/1471-2334-10-150
30. Parkins M. D., Sabuda D. M., Elsayed S., Laupland K. B., Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. Journal of Antimicrobial Chemotherapy 2007 60 3 613 618 2-s2.0-34548138992 10.1093/jac/dkm212 (Pubitemid 47299877)
31. Krishnan-Natesan S., Manavathu E. K., Cutright J. L., Chandrasekar P. H., Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. International Journal of Antimicrobial Agents 2010 36 1 33 36 2-s2.0-77953020219 10.1016/j.ijantimicag.2010.02.020
32. De Pauw B., Walsh T. J., Donnelly J. P., Stevens D. A., Edwards J. E., Calandra T., Pappas P. G., Maertens J., Lortholary O., Kauffman C. A., Denning D. W., Patterson T. F., Maschmeyer G., Bille J., Dismukes W. E., Herbrecht R., Hope W. W., Kibbler C. C., Kullberg B. J., Marr K. A., Muñoz P., Odds F. C., Perfect J. R., Restrepo A., Ruhnke M., Segal B. H., Sobel J. D., Sorrell T. C., Viscoli C., Wingard J. R., Zaoutis T., Bennett J. E., Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases 2008 46 12 1813 1821 2-s2.0-46249126149 10.1086/588660
33. Kauffman C. A., Marr K. A., Thorner R. A., Epidemiology and pathogenesis of candidemia in adults. 2011, http://www.uptodate.com/
34. Leroy O., Gangneux J.-P., Montravers P., Mira J.-P., Gouin F., Sollet J.-P., Carlet J., Reynes J., Rosenheim M., Regnier B., Lortholary O., Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Critical Care Medicine 2009 37 5 1612 1618 2-s2.0-67650508061 10.1097/CCM.0b013e31819efac0